Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Establishment Labs Holdings Inc. (ESTA) Cash Flow Statement

Establishment Labs Holdings Inc. (ESTA) generated -$32.3M of operating cash flow over the twelve months to 2026-06-30, spent $9.2M on capital expenditure and had free cash flow of -$41.5M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ESTAEstablishment Labs Holdings Inc.Follow ESTA — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
1.9B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days
LineFY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-33.9-30.0-12.5-27.5-52.2-88.5-58.5-50.9-32.3
Capital expenditure1.76.32.45.332.823.28.56.0-9.2
Free cash flow-35.6-36.3-14.9-32.8-84.9-111.7-67.0-56.9-41.5
Share repurchases0.0————————
Stock-based compensation—————14.414.411.4—

USD millions · SEC XBRL

Establishment Labs Holdings Inc. — questions

What is Establishment Labs Holdings Inc.'s operating cash flow?
-$32.3M over the twelve months to 2026-06-30.
How much does Establishment Labs Holdings Inc. spend on capital expenditure?
$9.2M over the twelve months to 2026-06-30.
What is Establishment Labs Holdings Inc.'s free cash flow?
-$41.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Establishment Labs Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.